Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,480 signal articles · 172 in last 24h · 116,612 total before filter · latest 17m ago
172last 24h
1719last 7d
282● bullish (7d)
154● bearish (7d)
205publishers
AllMacro321Earnings773M&A101Regulatory25Product16Analyst24
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Bank Stocks We’re Skeptical Of
StockStory14d agoneutral
3 Bank Stocks We’re Skeptical Of

Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. Still, investors are uneasy as banks face challenges from credit quality concerns and potential regulatory changes. These doubts have certainly contributed to banking stocks’ recent underperformance - over the past six months, the industry’s 6.5% gain has fallen behind the S&P 500’s 8.3% rise.

Visa’s Latest Deal Signals New Era in Fighting Digital Scams
Barrons.com14d agoneutral
Visa’s Latest Deal Signals New Era in Fighting Digital Scams

Visa’s latest deal could signal a new era in fighting digital scams as artificial intelligence-enabled fraud spreads. The payments giant plans to buy BioCatch, a provider of fraud intelligence technology, for $2.4 billion in cash. Visa said the addition of BioCatch will complement its current security efforts and help clients better protect themselves and their customers from the growing threat of account takeovers, scams, money mules, and application fraud.

The Dow and S&P 500 Flirt With Record Highs
Barrons.com14d agobullish
The Dow and S&P 500 Flirt With Record Highs

A broad rally has taken a hold of Wall Street, and the stock market is on track to set some record highs. New records were within reach for the Dow Jones Industrial Average and S&P 500. The Dow was up 0.9%, or 474 points, at 52,963.99.

DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential
Insider Monkey14d agobullish
DiaMedica Therapeutics (DMAC): BioTech with Breakthrough Potential

1 Main Capital, a boutique investment firm, recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. 1 Main Capital Partners returned 15.0% in Q2 2026, compared to 15.2% and 21.6% for the S&P 500 (SPX) and Russell 2000 (RTY), respectively. SPX and RTY delivered their best performance since 2026 […]

Hilton Grand Vacations (HGV) Turns Discounts in to Opportunity
Insider Monkey14d agoneutral
Hilton Grand Vacations (HGV) Turns Discounts in to Opportunity

1 Main Capital, a boutique investment firm, recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. 1 Main Capital Partners returned 15.0% in Q2 2026, compared to 15.2% and 21.6% for the S&P 500 (SPX) and Russell 2000 (RTY), respectively. SPX and RTY delivered their best performance since 2026 […]